January 28, 2015 11:53 AM ET


Company Overview of AxioMx, Inc.

Company Overview

AxioMx, Inc. discovers, develops, produces, and delivers recombinant antibodies against the human proteome. It also offers custom recombinant antibody discovery and development services ranging from peptide synthesis to large-scale antibody production. The company’s services include antigen and peptide synthesis, epitope mapping, phage display library screening and affinity maturation, and custom phage display library development; and antibody design, modification, optimization, and production. In addition, AxioMx, Inc. offers a range of custom antibody discovery and development services for the research and diagnostic market places. The company’s recombinant antibodies are used in western b...

688 East Main Street

Branford, CT 06405

United States

Founded in 2012





Key Executives for AxioMx, Inc.

Chief Executive Officer and President
Age: 58
Founder and Chief Scientific Officer
Executive Director
Director of Molecular Sciences
Director of Automation & Production
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Prospex Medical, Inc. United States
Jade Therapeutics, Inc. United States
Millennium Life Sciences, Inc. United States
Descartes Therapeutics United States
Enobia Pharma Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AxioMx, Inc., please visit www.axiomxinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.